| Otolaryngology |
1 |
1 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.9 |
| Chemotherapy |
0 |
0.72 |
| Esophageal Cancer |
0 |
0.63 |
| Esophagus |
0 |
0.47 |
| Cancer |
0 |
0.38 |
| Squamous Cell Carcinoma |
0 |
0.33 |
| Gastric Cancer |
0 |
0.3 |
| Toxicology |
0 |
0.25 |
| Tumor |
0 |
0.21 |
| Quality of Life |
0 |
0.2 |
| Adenocarcinoma |
0 |
0.17 |
| Adenocarcinoma of the Gastroesophageal Junction |
0 |
0.15 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Accomodation |
0 |
0.04 |
| Biomarker |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Malnutrition |
0 |
0.04 |
| Platinum |
0 |
0.04 |
| Radiation Therapy |
0 |
0.04 |
| Resection |
0 |
0.04 |
| Surgical Oncology |
0 |
0.04 |
| Travel Medicine |
0 |
0.04 |